FindTrial
Sign In

A study to assess whether giving less fluid help newborn babies with breathing problems recover better.

Evaluation of Efficacy of Restricted Fluid Management in Respiratory Distress Syndrome Neonates : A Randomised Controlled Trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107962
Enrollment
42
Registered
2026-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J99- Respiratory disorders in diseasesclassified elsewhere

Interventions

Intervention1: Restricted intravenous fluid administration: Neonates randomized to the intervention arm will receive restricted intravenous fluid therapy, defined as 70 perecnt of the conventional flu

Sponsors

JNMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Neonates with Respiratory Distress Syndrome.

Exclusion criteria

Exclusion criteria: Neonates with congenital malformations ,heart diseases

Design outcomes

Primary

MeasureTime frame
Duration of Respiratory Support is measured in hours from initiation to cessation of respiratory support (e.g., CPAP, mechanical ventilation)Timepoint: from birth to 28 days—

Secondary

MeasureTime frame
Time to first enteral feeding Timepoint: from birth to 28 days;Duration of NICU stayTimepoint: from birth to 28 days;Incidence of patent ductus arteriosusTimepoint: from birth to 28 days—

Countries

India

Contacts

Public ContactDr R J MESHRAM

JAWAHARLAL NEHRU MEDICAL COLLEGE

rjmeshram@yahoo.com9823763989

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026